China’s cosmetic regulations have undergone rigorous enhancements, requiring brands to disclose efficacy summaries and testing methodologies in product filings. This shift marks the industry’s transition into an “evidence-based efficacy” era, where products lacking scientific validation are being phased out. Meanwhile, time-tested ingredients like Pro-Xylane, retinoids, and peptides—proven through market validation—are solidifying their dominance, aligning with the “Matthew Effect” where Chinese domestic leaders strengthen their positions.
China’s Pro-Xylane market now exceeds ¥10 billion, growing at 18% CAGR. Advances in synthetic biology (e.g., CRISPR-edited microbial fermentation boosting yields by 60%) and industry standards (e.g., Jun Tai Pharma’s raw material guidelines) position Chinese domestic brands for global competition. MIXX’s R&D-driven strategy exemplifies China’s shift from “marketing-led” to “science-validated” cosmetics innovation.
Supplying pure powder of Bosein ,proxylane
© 2025. All Rights Reserved.